| TTM
|
12/31/2023
|
12/31/2022
|
12/31/2021
|
|
|---|---|---|---|---|
| Total Revenue
|
2,505,000 | 2,496,000 | 2,567,000 | 3,038,000 |
| Cost of Revenue
|
-2,721,000 | -2,684,000 | -2,667,000 | -2,908,000 |
|
Gross Profit
|
-216,000 | -188,000 | -100,000 | 130,000 |
| Selling, General and Administrative Expenses
|
-198,000 | -191,000 | -164,000 | -164,000 |
| Depreciation, Amortization and Depletion
|
-11,000 | -11,000 | -11,000 | -11,000 |
| Provision Expense/Write-Back
|
-7,000 | -14,000 | 23,000 | 25,000 |
| Other Income/Expense, Operating
|
3,000 | 3,000 | 10,000 | 0 |
|
Operating Income/Expenses
|
-213,000 | -213,000 | -142,000 | -150,000 |
|
Total Operating Profit/Loss
|
-429,000 | -401,000 | -242,000 | -20,000 |
| Total Net Finance Income/Expense
|
-106,000 | -113,000 | -91,000 | -38,000 |
| Net Investment Income
|
7,000 | 11,000 | 18,000 | -1,000 |
| Irregular Income/Expenses
|
-59,000 | -20,000 | -49,000 | -196,000 |
|
Non-Operating Income/Expenses, Total
|
-160,000 | -122,000 | -122,000 | -235,000 |
|
Pretax Income
|
-592,000 | -526,000 | -345,000 | -255,000 |
| Provision for Income Tax
|
5,000 | 3,000 | -2,000 | 13,000 |
|
Net Income from Continuing Operations
|
-587,000 | -523,000 | -347,000 | -242,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-587,000 | -523,000 | -347,000 | -242,000 |
|
Non-Controlling/Minority Interests
|
15,000 | 18,000 | 27,000 | -3,000 |
|
Net Income after Non-Controlling/Minority Interests
|
-572,000 | -505,000 | -320,000 | -245,000 |
|
Net Income Available to Common Stockholders
|
-572,000 | -505,000 | -320,000 | -245,000 |
|
Diluted Net Income Available to Common Stockholders
|
-572,000 | -505,000 | -320,000 | -245,000 |
| Basic EPS
|
-1.10 | -0.97 | -0.62 | -0.68 |
| Diluted EPS
|
-1.10 | -0.97 | -0.62 | -0.68 |
|
Basic Weighted Average Shares Outstanding
|
520,000 | 519,000 | 515,000 | 362,000 |
|
Diluted Weighted Average Shares Outstanding
|
520,000 | 519,000 | 515,000 | 362,000 |
|
Reported Normalized Basic EPS
|
-0.94 | -0.93 | -0.57 | 0.01 |
|
Reported Normalized Diluted EPS
|
-0.94 | -0.93 | -0.57 | 0.01 |
| Income Statement, Supplemental
|
||||
|
EBIT
|
-486,000 | -413,000 | -254,000 | -217,000 |
|
EBITDA
|
-406,000 | -257,000 | -106,000 | -130,000 |
12/31/2021 - 9/9/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade